tiprankstipranks
Trending News
More News >
Viking Therapeutics (DE:1VT)
NASDAQ:1VT
Germany Market

Viking Therapeutics (1VT) Cash flow

Compare
75 Followers

Viking Therapeutics Cash Flow

DE:1VT's free cash flow for Q4 2025 was $-85.29M. For the 2025 fiscal year, DE:1VT's free cash flow was decreased by $-190.90M and operating cash flow was $-85.29M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -278.69M$ -87.79M$ -73.38M$ -48.40M$ -47.59M
Investing Cash Flow
$ 341.39M$ -553.37M$ -179.09M$ 54.75M$ 37.96M
Financing Cash Flow
$ 76.44M$ 612.46M$ 271.38M$ 4.16M$ 6.88M
End Cash Position
$ 165.81M$ 26.68M$ 55.52M$ 36.63M$ 26.37M
Free Cash Flow
$ -278.69M$ -87.79M$ -73.38M$ -48.40M$ -47.59M
Currency in USD

Viking Therapeutics Cash Flow